Brain glutaminases

Biomolecular Concepts

Volumn 1, Issue 1, 2010, Pages 3-15

  Márquez, Javier ^a   Martín Rufián, Mercedes ^a   Segura, Juan A ^a   Matés, Jose M ^a   Campos Sandoval, Jose A ^b   Alonso, Francisco J ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

astrocytes; glutamate; glutaminase interacting proteins; glutamine; neurones

Indexed keywords

EID: 84872757487     PISSN: 18685021     EISSN: 1868503X     Source Type: Journal    
DOI: 10.1515/bmc.2010.006     Document Type: Review

References (117)

1. Márquez J, López de la Oliva AR, Matés JM, Segura JA, Alonso FJ. Glutaminase: A multifaceted protein not only involved in generating glutamate. Neurochem Int 2006; 48: 465-71.
2. Nicklas WJ, Zeevalk G, Hyndman A. Interactions between neurons and glia in glutamate/glutamine compartmentation. Biochem Soc Trans 1987; 15: 208-10.
3. Waagepetersen HS, Qu H, Sonnewald U, Shimamoto K, Schousboe A. Role of glutamine and neuronal glutamate uptake in glutamate homeostasis and synthesis during vesicular release in cultured glutamatergic neurons. Neurochem Int 2005; 47: 92-102.
4. Erecinska M, Silver IA. Metabolism and role of glutamate in mammalian brain. Prog Neurobiol 1990; 35: 245-96.
5. Fonnum F. Glutamate: A neurotransmitter in mammalian brain. J Neurochem 1984; 42: 1-11.
6. Kovacevic Z, McGivan JD. Mitochondrial metabolism of glutamine and glutamate and its physiological significance. Physiol Rev 1983; 63: 547-605.
7. Waelsch H. Amino acid and protein metabolism. In: Elliott KAC, Page IH, Quastel JH, editors. Neurochemistry, 2nd edn. Springfield, IL: Charles C. Thomas, 1962: 288-320.
8. Dingledine R, McBain C. Glutamate and aspartate. In: Siegel GJ, Agranoff BW, Uhler ME, editors. Basic Neurochemistry, 6th edn. Philadelphia, PA: Lippincott Raven, 1999: 315-34.
9. Pardridge WM, Oldendorf WH. Kinetic analysis of bloodbrain barrier transport of amino acids. Biochim Biophys Acta 1975; 401: 128-36.
10. Perea G, Navarrete M, Araque A. Tripartite synapses: Astrocytes process and control synaptic information. Trends Neurosci 2009; 32: 421-31.
11. Hertz L. Functional interactions between neurons and astrocytes. I. Turnover and metabolism of putative amino acid transmitters. Prog Neurobiol 1979; 13: 277-323.
12. Norenberg MD, Martínez-Hernández A. Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 1979; 161: 303-10.
13. Laake JH, Slyngstad TA, Haug FM, Ottersen OP. Glutamine from glial cells is essential for the maintenance of the nerve terminal pool of glutamate: Immunogold evidence from hippocampal slice cultures. J Neurochem 1995; 65: 871-81.
14. Kvamme E. Enzymes of cerebral glutamine metabolism. In: Häussinger D, Sies H, editors. Glutamine metabolism in mammalian tissues. Berlin: Springer Verlag, 1984: 32-48.
15. Chung-Bok M-I, Vincent N, Jhala U, Watford M. Rat hepatic glutaminase: Identification of the full coding sequence and characterization of a functional promoter. Biochem J 1997; 324: 193-200.
16. Pérez-Gómez C, Matés JM, Gómez-Fabre PM, del Castillo-Olivares A, Alonso FJ, Márquez J. Genomic organization and transcriptional analysis of the human L-glutaminase gene. Biochem J 2003; 370: 771-84.
17. Aledo JC, Gómez-Fabre PM, Olalla L, Márquez J. Identification of two human glutaminase loci and tissue-specific expression of the two related genes. Mammal Genome 2000; 11: 1107-10.
18. Mock B, Kozak C, Seldin MF, Ruff N, D'Hoostelaere L, Szpirer C, Levan G, Seuanez H, O'Brien S, Banner C. A glutaminase (gls) gene maps to mouse chromosome 1, rat chromosome 9, and human chromosome 2. Genomics 1989; 5: 291-7.
19. Elgadi KM, Meguid RA, Qian M, Souba WW, Abcouwer SF. Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol Genomics 1999; 1: 51-62.
20. Porter LD, Ibrahim H, Taylor L, Curthoys NP. Complexity and species variation of the kidney-Type glutaminase gene. Physiol Genomics 2002; 9: 57-66.
21. Nagase T, Ishikawa K, Suyama M, Kikuno R, Hirosawa M, Miyajima N, Tanaka A, Kotani H, Nombra N, Ohara O. Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res 1998; 5: 355-64.
22. Banner C, Hwang JJ, Shapiro RA, Wenthold RJ, Nakatani Y, Lampel KA, Thomas JW, Huie D, Curthoys NP. Isolation of a cDNA for rat brain glutaminase. Brain Res 1988; 427: 247-54.
23. Smith EM, Watford M. Molecular cloning of a cDNA for rat hepatic glutaminase. Sequence similarity to kidney-Type glutaminase. J Biol Chem 1990; 265: 10631-6.
24. Gómez-Fabre PM, Aledo JC, del Castillo-Olivares A, Alonso FJ, Núñez de Castro I, Campos JA, Márquez J. Molecular cloning, sequencing and expression studies of the human breast cancer cell glutaminase. Biochem J 2000; 345: 365-75.
25. de la Rosa V, Campos-Sandoval JA, Martín-Rufián M, Cardona C, Matés JM, Segura JA, Alonso FJ, Márquez J. A novel glutaminase isoform in mammalian tissues. Neurochem Int 2009; 55: 76-84.
26. Curthoys NP, Watford M. Regulation of glutaminase activity and glutamine metabolism. Annu Rev Nutr 1995; 15: 133-59.
27. Olalla L, Gutiérrez A, Campos JA, Khan ZU, Alonso F, Segura JA, Márquez J, Aledo JC. Nuclear localization of L-glutaminase in mammalian brain. J Biol Chem 2002; 277: 38939-44.
28. Turner A, McGivan JD. Glutaminase isoform expression in cell lines derived from human colorectal adenomas and carcinomas. Biochem J 2003; 370: 403-8.
29. Pérez-Gómez C, Campos-Sandoval JA, Alonso FJ, Segura JA, Manzanares E, Ruiz-Sánchez P, González ME, Márquez J, Matés JM. Co-expression of glutaminase K and L isoenzymes in human tumour cells. Biochem J 2005; 386: 535-42.
30. Kvamme E, Roberg B, Torgner IA. Phosphate activated glutaminase and mitochondrial glutamine transport in the brain. Neurochem Res 2000; 25: 1407-19.
31. Haser WG, Shapiro RA, Curthoys NP. Comparison of the phosphate-dependent glutaminase obtained from rat brain and kidney. Biochem J 1985; 229: 399-408.
32. Aoki C, Kaneko, T, Starr A, Pickel VM. Identification of mitochondrial and non-mitochondrial glutaminase within select neurons and glia of rat forebrain by electron microscopic immunocytochemistry. J Neurosci Res 1991; 28: 531-48.
33. Laake JH, Takumi Y, Eidet J, Torgner IA, Roberg B, Kvamme E, Ottersen OP. Postembedding immunogold labelling reveals subcellular localization and pathway-specific enrichment of phosphate activated glutaminase in rat cerebellum. Neuroscience 1999; 88: 1137-51.
34. Campos-Sandoval JA, López de la Oliva AR, Lobo C, Segura JA, Matés JM, Alonso FJ, Márquez J. Expression of functional human glutaminase in baculovirus system: Affinity purification, kinetic and molecular characterization. Int J Biochem Cell Biol 2007; 39: 765-73.
35. Nimmo GA, Tipton KF. Purification of soluble glutaminase from pig brain. Biochem Pharmacol 1980; 29: 359-67.
36. Roberg B, Torgner IA, Kvamme E. The orientation of phosphate activated glutaminase in the inner mitochondrial membrane of synaptic and non-synaptic rat brain mitochondria. Neurochem Int 1995; 27: 367-76.
37. Hertz L. Intercellular metabolic compartmentation in the brain: Past, present and future. Neurochem Int 2004; 45: 285-96.
38. Masson J, Darmon M, Conjard A, Chuhma N, Ropert N, Thoby-Brisson M, Foutz AS, Parrot S, Miller GM, Jorisch R, Polan J, Hamon M, Hen R, Rayport S. Mice lacking brain/ kidney phosphate-Activated glutaminase have impaired glutamatergic synaptic transmission, altered breathing, disorganized goal-directed behavior and die shortly after birth. J Neurosci 2006; 26: 4660-71.
39. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 2007; 445: 168-76.
40. Shen J, Petersen KF, Behar KL, Brown P, Nixon TW, Mason GF, Petroff OAC, Shulman GI, Shulman RG, Rothman DL. Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. Proc Natl Acad Sci 1999; 96: 8235-40.
41. Lebon V, Petersen KF, Cline GW, Shen J, Mason GF, Dufour S, Behar KL, Shulman GI, Rothman DL. Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: Elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. J Neurosci 2002; 22: 1523-31.
42. Magistretti PJ, Pellerin L, Rothman DL, Shulman RG. Energy on Demand. Science 1999; 283: 496-7.
43. Magistretti PJ, Pellerin L. Astrocytes couple synaptic activity to glucose utilization in the brain. News Physiol Sci 1999; 14: 177-82.
44. Gamberino WC, Berkich DA, Lynch CJ, Xu B, LaNoue KF. Role of pyruvate carboxylase in facilitation of synthesis of glutamate and glutamine in cultured astrocytes. J Neurochem 1997; 69: 2312-25.
45. Hutson SM, Berkich D, Drown P, Xu B, Aschner M, LaNoue KF. Role of branche-chain aminotransferase isoenzymes and gabapentin in neurotransmitter metabolism. J Neurochem 1998; 71: 863-74.
46. McKenna MC, Sonnewald U, Huang X, Hopkins IB. Exogenous glutamate concentration regulates the metabolic fate of glutamate in astrocytes. J Neurochem 1996; 66: 386-93.
47. Sibson NR, Dhankhar A, Mason GF, Behar KL, Rothman DL, Shulman RG. In vivo 13C NMR measurements of cerebral glutamine synthesis as evidence for glutamate-glutamine cycling. Proc Natl Acad Sci USA 1997; 94: 2699-704.
48. Gruetter R, Seaquist ER, Kim S, Ugurbil K. Localized in vivo 13C-NMR of glutamate metabolism in the human brain: Initial results at 4 tesla. Dev Neurosci 1998; 20: 380-8.
49. Shen J, Sibson NR, Cline G, Behar KL, Rothman DL, Shulman RG. 15N-NMR spectroscopy study of ammonia transport and glutamine synthesis in the hyperammonemic rat brain. Dev Neurosci 1998; 20: 434-43.
50. Waagepetersen HS, Sonnewald U, Larsson OM, Schousboe A. A possible role of alanine for ammonia transfer between astrocytes and glutamatergic neurons. J Neurochem 2000; 75: 471-9.
51. Maciejewski PK, Rothman DL. Proposed cycles for functional glutamate trafficking in synaptic neurotransmission. Neurochem Int 2008; 52: 809-25.
52. Rothman DL, Sibson NR, Hyder F, Shen J, Behar KL, Shulman RG. In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics. Philos Trans R Soc Lond B 1999; 354: 1165-77.
53. McKenna MC, Tildon JT, Stevenson JH, Boatright R, Huang S. Regulation of energy metabolism in synaptic terminals and cultured rat brain astrocytes: Differences revealed using aminooxyacetate. Dev Neurosci 1993; 15: 320-9.
54. McKenna MC. The glutamate-glutamine cycle is not stoichiometric: Fates of glutamate in brain. J Neurosci Res 2007; 85: 3347-58.
55. Ramos M, del Arco A, Pardo B, Martínez-Serrano A, Martí-nez-Morales JR, Kobayashi K, Yasuda T, Bogonez E, Bovolenta P, Saheki T, Satrústegui J. Developmental changes in the Ca2q-regulated mitochondrial aspartate-glutamate carrier aralar1 in brain and prominent expression in the spinal cord. Dev Brain Res 2003; 143: 33-46.
56. Berckich DA, Ola MS, Cole J, Sweatt AJ, Hutson SM. Mitochondrial transport proteins of the brain. J Neurosci Res 2007; 85: 3367-77.
57. Jalil MA, Begum L, Contreras L, Pardo B, Iijima M, Li MX, Ramos M, Marmol P, Horiuchi M, Shimotsu K, Nakagawa S, Okubo A, Sameshima M, Isashiki Y, del Arco A, Kobayashi K, Satrústegui J, Saheki T. Reduced N-Acetylaspartate levels in mice lacking aralar, a brain- And muscle-Type mitochondrial aspartate-glutamate carrier. J Biol Chem 2005; 280: 31333-9.
58. Satrústegui J, Contreras L, Ramos M, Marmol P, del Arco A, Saheki T, Pardo P. Role of aralar, the mitochondrial transporter of aspartate-glutamate, in brain N-Acetylaspartate formation and Ca2q signaling in neuronal mitochondria. J Neurosci Res 2007; 85: 3359-66.
59. Roberg B, Torgner IA, Kvamme E. Inhibition of glutamine transport in rat brain mitochondria by some amino acids and tricarboxylic acid cycle intermediates. Neurochem Res 1999; 24: 811-6.
60. Albrecht J, Sonnewald U, Waagepetersen HS, Schousboe A. Glutamine in the central nervous system: Function and dysfunction. Front Biosci 2007; 12: 332-43.
61. Matés JM, Segura JA, Campos-Sandoval JA, Lobo C, Alonso L, Alonso FJ, Márquez J. Glutamine homeostasis and mitochondrial dynamics. Int J Biochem Cell Biol 2009; 41: 2051-61.
62. Fonseca LL, Monteiro MAR, Alves PM, Carrondo MJT, Santos H. Cultures of rat astrocytes challenged with a steady supply of glutamate: New model to study flux distribution in the glutamate-glutamine cycle. Glia 2005; 51: 286-96.
63. Schousboe A, Hertz L, Svenneby G, Kvamme E. Phosphate activated glutaminase activity and glutamine uptake in primary cultures of astrocytes. J Neurochem 1979; 32: 943-50.
64. Kvamme E, Svenneby G, Hertz L, Schousboe A. Properties of phosphate activated glutaminase in astrocytes cultured from mouse brain. Neurochem Res 1982; 7: 761-70.
65. Yudkoff M, Nissim I, Pleasure D. Astrocyte metabolism of w15Nxglutamine: Implications for the glutamine-glutamate cycle. J Neurochem 1988; 51: 843-50.
66. Szeliga M, Matyja E, Obara M, Grajkowska W, Czernicki T, Albrecht J. Relative expression of mRNAs coding for glutaminase isoforms in CNS tissues and CNS tumors. Neurochem Res 2008; 33: 808-13.
67. Wurdig S, Kugler P. Histochemistry of glutamate metabolizing enzymes in the rat cerebellar cortex. Neurosci Lett 1991; 130: 165-8.
68. Olalla L, Gutiérrez A, Jiménez AJ, López-Téllez JF, Khan ZU, Pérez J, Alonso FJ, de la Rosa V, Campos-Sandoval JA, Segura JA, Aledo JC, Márquez J. Expression of scaffolding PDZ protein GIP (glutaminase-interacting-protein) in mammalian brain. J Neurosci Res 2008; 86: 281-92.
69. Olalla L, Aledo JC, Bannenberg G, Márquez J. The C-Terminus of human glutaminase L mediates association with PDZ domain-containing proteins. FEBS Lett 2001; 488: 116-22.
70. Ponting CP, Phillips C, Davies KE, Blake DJ. PDZ domains: Targeting signalling molecules to sub-membranous sites. Bioessays 1997; 19: 469-79.
71. Aledo JC, Rosado A, Olalla L, Campos JA, Márquez J. Overexpression, purification, and characterization of glutaminaseinteracting protein, a PDZ-domain protein from human brain. Protein Expr Purif 2001; 23: 411-8.
72. Kausalya PJ, Phua DC, Hunziker W. Association of ARVCF with zonula occludens (ZO)-1 and ZO-2: Binding to PDZdomain proteins and cell-cell adhesion regulate plasma membrane and nuclear localization of ARVCF. Mol Biol Cell 2004; 15: 5503-15.
73. Häussinger D, Schliess F. Glutamine metabolism and signaling in the liver. Front Biosci 2007; 12: 371-91.
74. Curi R, Newsholme P, Procopio J, Lagranha C, Gorjão R, Pithon-Curi TC. Glutamine, gene expression, and cell function. Front Biosci 2007; 12: 344-57.
75. Szeliga M, Obara-Michlewska M, Matyja E, Lazarczyk M, Lobo C, Hilgier W, Alonso F, Márquez J, Albrecht J. Transfection with liver-Type glutaminase (LGA) cDNA alters gene expression and reduces viability, migration and proliferation of T98G glioma cells. Glia 2009; 57: 1014-23.
76. Szeliga M, Sidoryk M, Matyja E, Kowalczyk P, Albrecht J. Lack of expression of the liver-Type glutaminase (LGA) mRNA in human malignant gliomas. Neurosci Lett 2005; 374: 171-3.
77. Kaneko T, Mizuno N. Immunohistochemical study of glutaminase-containing neurons in the cerebral cortex and thalamus of the rat. J Comp Neurol 1988; 267: 590-602.
78. Koehler RC, Gebremedhin D, Harder DR. Role of astrocytes in cerebrovascular regulation. J Appl Physiol 2006; 100: 307-17.
79. Fergus A, Lee KS. Regulation of cerebral microvessels by glutamatergic mechanisms. Brain Res 1997; 754: 35-45.
80. Nedergaard M, Takano T, Hansen AJ. Beyond the role of glutamate as a neurotransmitter. Nat Rev Neurosci 2002; 3: 748-55.
81. Collard CD, Park KA, Montalto MC, Alapati S, Buras JA, Stahl GL, Colgan SP. Neutrophil-derived glutamate regulates vascular endothelial barrier function. J Biol Chem 2002; 277: 14801-11.
82. Buschdorf JP, Chew LL, Zhang B, Cao Q, Liang FY, Liou YC, Zhou YT, Low BC. Brain-specific BNIP-2-homology protein caytaxin relocalises glutaminase to neurite terminals and reduces glutamate levels. J Cell Sci 2006; 119: 3337-50.
83. Low BC, Seow KT, Guy GR. Evidence for a novel Cdc42GAP domain at the carboxyl terminus of BNIP-2. J Biol Chem 2000; 275: 14415-22.
84. Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 1990; 13: 171-82.
85. Newcomb R, Sun X, Taylor L, Curthoys N, Giffard RG. Increased production of extracellular glutamate by the mitochondrial glutaminase following neuronal death. J Biol Chem 1997; 272: 11276-82.
86. Newcomb R, Pierce AR, Kano T, Meng W, Bosque-Hamilton P, Taylor L, Curthoys N, Lo EH. Characterization of mitochondrial glutaminase and amino acids at prolonged times after experimental focal cerebral ischemia. Brain Res 1998; 813: 103-11.
87. Chamoun RB, Suki D, Gopinath S, Robertson C. The role of extracellular glutamate measured by cerebral microdialysis in severe traumatic brain injury wabstractx. In: 77th Annual Meeting of the American Association of Neurological Surgeons (AANS), 2009. San Diego, CA, USA. May 2-6, 2009.
88. Willis C, Lybrand S, Bellamy N. Excitatory amino acid inhibitors for traumatic brain injury. Cochrane Database Syst Rev 2003; 1: CD003986.
89. Ramonet D, Rodríguez MJ, Fredriksson K, Bernal F, Mahy N. In vivo neuroprotective adaptation of the glutamate/ glutamine cycle to neuronal death. Hippocampus 2004; 14: 586-94.
90. During MJ, Spencer DD. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 1993; 341: 1607-10.
91. Eid T, Williamson A, Lee T-SW, Petroff OA, de Lanerolle NC. Glutamate and astrocytes - Key players in human mesial temporal lobe epilepsy?. Epilepsia 2008; 49: 42-52.
92. Eid T, Thomas MJ, Spencer DD, Runden-Pran E, Lai JC, Malthankar GV, Kim JH, Danbolt NC, Ottersen OP, de Lanerolle NC. Loss of glutamine synthetase in the human epileptogenic hippocampus: Possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy. Lancet 2004; 363: 28-37.
93. Steffens M, Huppertz H-J, Zentner J, Chauzit E, Feuerstein TJ. Unchanged glutamine synthetase activity and increased NMDA receptor density in epileptic human neocortex: Implications for the pathophysiology of epilepsy. Neurochem Int 2005; 47: 379-84.
94. Hammer J, Alvestad S, Osen KK, SkareÖ, Sonnewald U, Ottersen OP. Expression of glutamine synthetase and glutamate dehydrogenase in the latent phase and chronic phase in the kainite model of temporal lobe epilepsy. Glia 2008; 56: 856-68.
95. Eid T, Hammer J, Rundén-Pran E, Roberg B, Thomas MJ, Osen K, Davanger S, Laake P, Torgner IA, Lee T-SW, Kim JH, Spencer DD, Ottersen OP, de Lanerolle NC. Increased expression of phosphate-Activated glutaminase in hippocampal neurons in human mesial temporal lobe epilepsy. Acta Neuropathol 2007; 113: 137-52.
96. Tian G-F, Azmi H, Takano T, Xu Q, Peng W, Lin J, Oberheim NA, Lou N, Zielke R, Kang J, Nedergaard M. An astrocytic basis of epilepsy. Nat Med 2005; 11: 973-81.
97. Haroutunian V, Dracheva S, Davis KL. Neurobiology of glutamatergic abnormalities in schizophrenia. Clin Neurosci Res 2003; 3: 67-76.
98. Moghaddam B. Bringing order to the glutamate chaos in schizophrenia. Neuron 2003; 40: 881-4.
99. Javitt DC. Glutamate and schizophrenia: Phencyclidine, Nmethyl-D-Aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol 2007; 78: 69-108.
100. van Elst LT, Valerius G, Büchert M, Thiel T, Rüsch N, Bubl E, Hennig J, Ebert D, Olbrich HM. Increased prefrontal and hippocampal glutamate concentration in schizophrenia: Evidence from a magnetic resonance spectroscopy study. Biol Psychiatry 2005; 58: 724-30.
101. Smith RE, Haroutunian V, Davis KL, Meador-Woodruff JH. Expression of glutaminase transcripts in the thalamus in schizophrenia. Biol Psychiatry 2002; 51: 25.
102. Bruneau EG, McCullumsmith RE, Haroutunian V, Davis KL, Meador-Woodruff JH. Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia. Schizophr Res 2005; 75: 27-34.
103. Gluck MR, Thomas RG, Davis KL, Haroutunian V. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients. Am J Psychiatry 2002; 159: 1165-73.
104. Martin MV, Rollins B, Sequeira PA, Mesén A, Byerley W, Stein R, Moon EA, Akil H, Jones EG, Watson SJ, Barchas J, DeLisi LE, Myers RM, Schatzberg A, Bunney WE, Vawter MP. Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation. BMC Med Genomics 2009; 2: 62-79.
105. Moghaddam B, Adams BW. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 1998; 281: 1349-52.
106. Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV, Avedisova AS, Bardenstein LM, Gurovich IY, Morozova MA, Mosolov SN, Neznanov NG, Reznik AM, Smulevich AB, Tochilov VA, Johnson BG, Monn JA, Schoepp DD. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized phase 2 clinical trial. Nat Med 2007; 13: 1102-7.
107. Maeshima H, Ohnuma T, Sakai Y, Shibata N, Baba H, Ihara H, Higashi M, Ohkubo T, Nozawa E, Abe S, Ichikawa A, Nakano Y, Utsumi Y, Suzuki T, Arai H. Increased plasma glutamate by antipsychotic medication and its relationship to glutaminase 1 and 2 genotypes in schizophrenia - Juntendo University Schizophrenia Projects (JUSP). Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1410-8.
108. Sherman AD, Hamrah M, Mott J. Effects of neuroleptics on glutaminase from rat synaptosomes. Neurochem Res 1988; 13: 535-8.
109. Gaisler-Salomon I, Schobel SA, Small SA, Rayport S. How high-resolution basal-state functional imaging can guide the development of new pharmacotherapies for schizophrenia. Schizophr Bull 2009; 35: 1037-44.
110. Gaisler-Salomon I, Miller GM, Chuhma N, Lee S, Zhang H, Ghoddoussi F, Lewandowski N, Fairhurst S, Wang Y, Conjard-Duplany A, Masson J, Balsam P, Hen R, Arancio O, Galloway MP, Moore HM, Small SA, Rayport S. Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: Relevance to schizophrenia. Neuropsychopharmacology 2009; 34: 2305-22.
111. Jenkins BG, Klivenyi P, Kustermann E, Andreassen OA, Ferrante RJ, Rosen BR, Beal MF. Nonlinear decrease over time in N-Acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice. J Neurochem 2000; 74: 2108-19.
112. Albrecht J, Norenberg MD. Glutamine: A Trojan horse in ammonia neurotoxicity. Hepatology 2006; 44: 788-94.
113. Häussinger D, Kircheis G, Fischer R, Schliess F, vom Dahl S. Hepatic encephalopathy in chronic liver disease: A clinical manifestation of astrocyte swelling and low grade cerebral edema. J Hepatol 2000; 32: 1035-8.
114. Norenberg MD, Jayakumar AR, Rama Rao KV, Panickar KS. New concepts in the mechanism of ammonia-induced astrocyte swelling. Metab Brain Dis 2007; 22: 219-34.
115. Bai G, Rama Rao KV, Murthy CR, Panickar KS, Jayakumar AR, Norenberg MD. Ammonia induces the mitochondrial permeability transition in primary cultures of rat astrocytes. J Neurosci Res 2001; 66: 981-91.
116. Blei AT, Olafsson S, Therrien G, Butterworth RF. Ammoniainduced brain edema and intracranial hypertension in rats after portacaval anastomosis. Hepatology 1994; 19: 1437-44.
117. Norenberg MD, Rama Rao KV, Jayakumar AR. Ammonia neurotoxicity and the mitochondrial permeability transition. J Bioenerg Biomembr 2004; 36: 303-7.